PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Global Health and the Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Avera Research Institute, Sioux Falls, SD, USA.\', \'Clinical Research Solutions, Jackson, TN, USA.\', \'LumiraDx UK, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ajcp/aqab173
?:hasPublicationType
?:journal
  • American journal of clinical pathology
is ?:pmid of
?:pmid
?:pmid
  • 34668536
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 113
is ?:relation_isRelatedTo_publication of
?:title
  • Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all